![]() |
Volumn 36, Issue 1, 2011, Pages 363-364
|
New horizons for selective 5-HT2C receptor ligands in psychiatric/neurological disorders
|
Author keywords
[No Author keywords available]
|
Indexed keywords
LORCASERIN;
SEROTONIN 2C AGONIST;
SEROTONIN 2C RECEPTOR;
VABICASERIN;
ABSENCE OF SIDE EFFECTS;
CLINICAL TRIAL;
FAILURE TO THRIVE;
HUMAN;
HYPERPHAGIA;
MENTAL DISEASE;
MUSCLE HYPOTONIA;
NEUROLOGIC DISEASE;
NEUROTRANSMISSION;
OBESITY;
PHENOTYPE;
PRADER WILLI SYNDROME;
PRIORITY JOURNAL;
RNA EDITING;
SHORT SURVEY;
UNSPECIFIED SIDE EFFECT;
ANIMALS;
BRAIN CHEMISTRY;
DELIRIUM, DEMENTIA, AMNESTIC, COGNITIVE DISORDERS;
DISEASE MODELS, ANIMAL;
HUMANS;
LIGANDS;
MICE;
RECEPTOR, SEROTONIN, 5-HT2C;
SEROTONIN ANTAGONISTS;
SEROTONIN RECEPTOR AGONISTS;
|
EID: 78649652034
PISSN: 0893133X
EISSN: None
Source Type: Journal
DOI: 10.1038/npp.2010.168 Document Type: Short Survey |
Times cited : (5)
|
References (7)
|